🚀 VC round data is live in beta, check it out!
Subgen AI Valuation Multiples
Discover revenue and EBITDA valuation multiples for Subgen AI and similar public comparables like Tandem Diabetes Care, Oculis Holding, PROCEPT BioRobotics, Pulse Biosciences and more.
Subgen AI Overview
About Subgen AI
Subgen AI AB is an enterprise artificial intelligence company that develops both infrastructure and proprietary agent-centric AI-as-a-Service software, branded as Serenity Star. Its solutions are designed to scale and accelerate the adoption of AI across organizations. It is experiencing rapid growth, building data centers and delivering services to clients in sectors such as healthcare, energy, legal, and human resources. Subgen AI operates across Europe, Latin America, and the United States.
Founded
2019
HQ
Employees
15
Website
Sectors
Financials (FY)
EV
$1B
Subgen AI Financials
Subgen AI reported last fiscal year revenue of $22M and negative EBITDA of ($5M).
In the same fiscal year, Subgen AI generated $18M in gross profit, ($5M) in EBITDA losses, and had net loss of ($10M).
Subgen AI P&L
In the most recent fiscal year, Subgen AI reported revenue of $22M and EBITDA of ($5M).
Subgen AI expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $22M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $18M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 82% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (24%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (34%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($10M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (43%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Subgen AI Stock Performance
Subgen AI has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Subgen AI's stock price is $1.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.2% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSubgen AI Valuation Multiples
Subgen AI trades at 61.5x EV/Revenue multiple, and (257.9x) EV/EBITDA.
Subgen AI Financial Valuation Multiples
As of April 11, 2026, Subgen AI has market cap of $1B and EV of $1B.
Equity research analysts estimate Subgen AI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Subgen AI has a P/E ratio of (140.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 61.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (257.9x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (182.1x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 75.2x | XXX | XXX | XXX |
| P/E | — | XXX | (140.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (158.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Subgen AI Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Subgen AI Margins & Growth Rates
Subgen AI's revenue in the last fiscal year declined by (100%).
Subgen AI's revenue per employee in the last FY averaged $1.5M, while opex per employee averaged $1.7M for the same period.
Subgen AI Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (24%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 56% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.7M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 115% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Subgen AI Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Tandem Diabetes Care | XXX | XXX | XXX | XXX | XXX | XXX |
| Oculis Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| PROCEPT BioRobotics | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulse Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Enovis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Subgen AI M&A Activity
Subgen AI acquired XXX companies to date.
Last acquisition by Subgen AI was on XXXXXXXX, XXXXX. Subgen AI acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Subgen AI
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSubgen AI Investment Activity
Subgen AI invested in XXX companies to date.
Subgen AI made its latest investment on XXXXXXXX, XXXXX. Subgen AI invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Subgen AI
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Subgen AI
| When was Subgen AI founded? | Subgen AI was founded in 2019. |
| Where is Subgen AI headquartered? | Subgen AI is headquartered in United States. |
| How many employees does Subgen AI have? | As of today, Subgen AI has over 15 employees. |
| Is Subgen AI publicly listed? | Yes, Subgen AI is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Subgen AI? | Subgen AI trades under MAGNA ticker. |
| When did Subgen AI go public? | Subgen AI went public in 2020. |
| Who are competitors of Subgen AI? | Subgen AI main competitors are Tandem Diabetes Care, Oculis Holding, PROCEPT BioRobotics, Pulse Biosciences. |
| What is the current market cap of Subgen AI? | Subgen AI's current market cap is $1B. |
| What is the current revenue of Subgen AI? | Subgen AI's last fiscal year revenue is $22M. |
| What is the current EV/Revenue multiple of Subgen AI? | Current revenue multiple of Subgen AI is 61.5x. |
| Is Subgen AI profitable? | No, Subgen AI is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.